Request Access to GTRx logo

Genome-To-Treatment (GTRx™) is a first step in ending the therapeutic odyssey for rare genetic conditions.

drawing of a doctor in front of a computer monitorGTRx is a virtual, automated system for frontline clinicians in intensive care settings that provides immediate management plans for critically ill infants and children with a new diagnosis of an identified rare genetic disease.
Fill out our short form to request access to GTRx

GTRx is intended to provide immediate guidance to frontline neonatologists and intensivists to optimal therapies for critically ill infants and children in intensive care units as time is of the essence.

Stephen Kingsmore, MD, DSc, RCIGM President & CEO

About Rady Children’s Institute for Genomic Medicine® 

Rady Children’s Institute for Genomic Medicine is a non-profit research organization embedded within Rady Children’s Hospital-San Diego. 

RCIGM offers the highest quality rapid and ultra-rapid clinical whole genome sequencing. Learn more about the clinical services we offer. 

Along with optimizing our genome sequencing platform and Rapid Precision Medicine delivery system, we are scaling and sharing our tools and expertise in rare disease with a growing network of children’s hospitals globally to make cutting edge healthcare widely available

Contact Us About BeginNGS